Login Sign Up Contact Us
Countries

Categories

Romidepsin

TypeName: Business Offer
Country: United States
Summary: Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been demonstrated.https://www.creative-peptides.com/product/romidepsin-item-10-101-186-33671.html
Description:
Advantages:
Comments:
RequestId: 739
Name:Cathy Miller
Telphone:
Email:contact@creative-peptides.com

Special Business
OMG locksmith
Centered Recovery Programs
Willow Lake Dental
Sparkling Clean of East Texas
Footprint Adventure
Bollards Direct
United States